George C. Petrocheilos

Managing Partner · Catalio Capital Management · New York, United States

Decision maker

Email

Verified, deliverable email

Co-Founder & Managing Partner at Catalio Capital Management

Stages: Seed, Series A
Sectors: Health tech
Cheque size: €92k–€4.6M
Location: New York, United States
Freshness: Verified today

Notable investments

Clasp TherapeuticsSeries A · $150M · 2024
Haystack OncologySeries A · $56M · 2022
AnagenexSeries A · $30M · 2022
Pheast TherapeuticsSeries A · $76M · 2022
Octant BioSeries B · $80M · 2022
DNA ScriptSeries C · $170M · 2021
Sensei BiotherapeuticsSeries B · $30M · 2021
Spiral TherapeuticsSeries A · $6M · 2018

Frequently co-invests with

R. Jacob VogelsteinCatalio Capital3×Andrea van ElsasThird Rock VenturesChristian AngermayerPresight CapitalClint KorverUlu VenturesEli CasdinCasdin CapitalJack NielsenVivo CapitalJoachim RotheEQT Life SciencesJorge CondeAndreessen HorowitzJoško BobanovićSofinnova PartnersKatie HaunHaun VenturesLars Fjeldsoe-Nielsen2xNLing WongHighbury Group

Background

Co-Founder & Managing PartnerCatalio Capital Management2020–present
General PartnerCamden Partners2014–2020
Analyst - Project FinanceConstellation Energy2011–2011

In the press

Catalio Capital Amasses $381 Million for Third Biomedical Fund

Related lists

Health tech investors Seed Health tech in United States Series A Health tech in United States

Similar investors

Rishi GuptaPartner, OrbiMed

Ralph (Chris) ChristoffersenPartner, Morgenthaler Ventures

Blake PateAnalyst, Bios Partners

Raj ParekhGeneral Partner, Advent Life Sciences

Reinhard VogtVenture Partner, Dynamk Capital

Richard WellsManaging Director, Insight Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you George C. Petrocheilos? Request removal of this listing.